Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;19(3):174-185.
doi: 10.1007/s11901-020-00532-y. Epub 2020 Jul 11.

Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation

Kelley Weinfurtner  1 , Kimberly Forde  1   2
Affiliations

Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation

Kelley Weinfurtner et al. Curr Hepatol Rep. 2020 Sep.

Abstract

Purpose of review: Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PoPH) are both pulmonary vascular complications of advanced liver disease; however, these syndromes have distinct pathophysiology, clinical implications, and management.

Recent findings: While both conditions are associated with portal hypertension, HPS results from diffuse pulmonary capillary vasodilation and PoPH results from vasoconstriction and vascular remodeling of pulmonary arteries. In HPS, no medical therapies clearly improve outcomes; however, patients have excellent post-LT outcomes with near uniform reversal of hypoxemia. In PoPH, several medical therapies used in idiopathic pulmonary hypertension have been shown improve pulmonary hemodynamics, symptoms, and potentially LT outcomes; however, further study is needed to determine best treatment regimens, long-term outcomes on medical therapy, and role of LT.

Summary: While HPS results in severe hypoxemia that is usually reversible by LT, PoPH patients develop progressive pulmonary hypertension that may improve with medical therapy.

Keywords: arterial hypoxemia with elevated A-a gradient; hepatopulmonary syndrome; intravascular pulmonary dilation; liver transplant evaluation; portopulmonary hypertension; pulmonary hypertension medical therapy.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors have no conflicts of interest to disclose.

Figures

Figure 1:
Figure 1:
Pathophysiology of Hepatopulmonary Syndrome (A) and Portopulmonary Hypertension (B). ET: endothelin 1; TNF-alpha: tumor necrosis factor- alpha; IL-6: interleukin-6; NO: nitrous oxide; VEGF: vascular endothelial growth factor; CO: carbon monoxide; AV: arteriovenous; V-Q mismatch: ventilation-perfusion mismatch; R -> L: right to left. Figure made using BioRender graphics.
Figure 2:
Figure 2:
Work-up for Hepatopulmonary Syndrome (HPS). Portal HTN: portal hypertension; LT: liver transplant; TTE: transthoracic echocardiography; IPVD: intrapulmonary vascular dilation; ABG: arterial blood gas; A-a gradient: alveolar-arterial oxygen gradient; PaO2: partial pressure of arterial oxygen; MELD: model for end-stage liver disease.
Figure 3:
Figure 3:
Work-up for Portopulmonary Hypertension (PoPH). Portal HTN: portal hypertension; LT: liver transplant; TTE: transthoracic echocardiography; PAH: pulmonary arterial hypertension; mPAP: mean pulmonary artery pressure; PCWP: pulmonary capillary wedge pressure; PVR: pulmonary vascular resistance; CI: cardiac index; WHO II-IV: World Health Organization functional class II-IV; RVSP: right ventricular systolic pressure; RV: right ventricle; ePVR: estimated pulmonary vascular resistance; ERS: European Respiratory Society
See this image and copyright information in PMC

References

    1. Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB, Barberá JA, Cáneva JO, et al. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J. 2004. November;24(5):861–80. - PubMed
    1. De BK, Sen S, Biswas PK, Mandal SK, Das D, Das U, et al. Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression. Gastroenterology. 2002;122(4):897–903. - PubMed
    1. Regev A, Yeshurun M, Rodriguez M, Sagie A, Neff GW, Molina EG, et al. Transient hepatopulmonary syndrome in a patient with acute hepatitis A. J Viral Hepat. 2001;8(1):83–6. - PubMed
    1. Teuber G, Teupe C, Dietrich CF, Caspary WF, Buhl R, Zeuzem S. Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis. Eur J Intern Med. 2002;13(5):311–8. - PubMed
    1. Baiges A, Turon F, Simón-Talero M, Tasayco S, Bueno J, Zekrini K, et al. Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study. Hepatology. 2020;71(2):658–69. - PubMed

LinkOut - more resources